Novartis AG is bracing for lower profitability this year as key products like top-selling blood pressure drug Diovan face competition from cheaper rivals, the Swiss drugmaker said as it posted an 8 percent rise in quarterly earnings.
Popular Posts:
- Aetna 3Q profit jumps 53 percent on lower costs
- Democrats to Dump Obama in 2012? « rjjrdq's America II
- Mindray Medical posts lower profit in 3Q
- Aetna 3Q profit jumps 53 percent on lower costs
- Analyst gauges financial loss from Novartis recall